Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

Similar articles for PubMed (Select 22551095)

1.

Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast.

Wurtz N, Pascual A, Marin-Jauffre A, Bouchiba H, Benoit N, Desbordes M, Martelloni M, Pommier de Santi V, Richa G, Taudon N, Pradines B, Briolant S.

Malar J. 2012 May 2;11:146.

2.

Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.

Sutherland CJ, Laundy M, Price N, Burke M, Fivelman QL, Pasvol G, Klein JL, Chiodini PL.

Malar J. 2008 Nov 20;7:240. doi: 10.1186/1475-2875-7-240.

3.
4.

Plasmodium falciparum malaria and atovaquone-proguanil treatment failure.

Durand R, Prendki V, Cailhol J, Hubert V, Ralaimazava P, Massias L, Bouchaud O, Le Bras J.

Emerg Infect Dis. 2008 Feb;14(2):320-2. doi: 10.3201/eid1402.070945.

5.

Malarone treatment failure not associated with previously described mutations in the cytochrome b gene.

Wichmann O, Muehlen M, Gruss H, Mockenhaupt FP, Suttorp N, Jelinek T.

Malar J. 2004 Jun 8;3:14.

6.

Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.

Wichmann O, Muehlberger N, Jelinek T, Alifrangis M, Peyerl-Hoffmann G, Muhlen M, Grobusch MP, Gascon J, Matteelli A, Laferl H, Bisoffi Z, Ehrhardt S, Cuadros J, Hatz C, Gjorup I, McWhinney P, Beran J, da Cunha S, Schulze M, Kollaritsch H, Kern P, Fry G, Richter J; European Network on Surveillance of Imported Infectious Diseases.

J Infect Dis. 2004 Nov 1;190(9):1541-6. Epub 2004 Sep 28.

7.

Failure of atovaquone-proguanil malaria chemoprophylaxis in a traveler to Ghana.

Boggild AK, Lau R, Reynaud D, Kain KC, Gerson M.

Travel Med Infect Dis. 2015 Jan-Feb;13(1):89-93. doi: 10.1016/j.tmaid.2014.12.010. Epub 2014 Dec 31.

PMID:
25582377
8.

Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.

Deye GA, Miller RS, Miller L, Salas CJ, Tosh D, Macareo L, Smith BL, Fracisco S, Clemens EG, Murphy J, Sousa JC, Dumler JS, Magill AJ.

Clin Infect Dis. 2012 Jan 15;54(2):232-9. doi: 10.1093/cid/cir770. Epub 2011 Nov 3.

9.

Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola.

Pimentel S, Nogueira F, Benchimol C, Quinhentos V, Bom J, Varandas L, do Rosário V, Bernardino L.

Malar J. 2006 Apr 5;5:30.

10.

The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment.

Maude RJ, Nguon C, Dondorp AM, White LJ, White NJ.

Malar J. 2014 Sep 24;13:380. doi: 10.1186/1475-2875-13-380.

11.

Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children.

Tahar R, Almelli T, Debue C, Foumane Ngane V, Djaman Allico J, Whegang Youdom S, Basco LK.

J Infect Dis. 2014 Dec 15;210(12):1962-71. doi: 10.1093/infdis/jiu341. Epub 2014 Jun 18.

PMID:
24943722
13.

Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.

Krudsood S, Patel SN, Tangpukdee N, Thanachartwet W, Leowattana W, Pornpininworakij K, Boggild AK, Looareesuwan S, Kain KC.

Am J Trop Med Hyg. 2007 Apr;76(4):655-8.

14.

Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.

Musset L, Bouchaud O, Matheron S, Massias L, Le Bras J.

Microbes Infect. 2006 Sep;8(11):2599-604. Epub 2006 Aug 10.

PMID:
16962361
15.

Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.

Happi CT, Gbotosho GO, Folarin OA, Milner D, Sarr O, Sowunmi A, Kyle DE, Milhous WK, Wirth DF, Oduola AM.

Malar J. 2006 Oct 4;5:82.

16.

Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.

Musset L, Pradines B, Parzy D, Durand R, Bigot P, Le Bras J.

J Antimicrob Chemother. 2006 Jan;57(1):110-5. Epub 2005 Nov 30.

17.

[Value of malarone in therapy of malaria tropica].

Ziegler T, Schau A, Winkler C.

Med Klin (Munich). 2002 Aug 15;97(8):455-8. Review. German.

PMID:
12229244
18.

Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border.

Naoshima-Ishibashi Y, Iwagami M, Kawazu S, Looareesuwan S, Kano S.

Travel Med Infect Dis. 2007 Mar;5(2):132-4. Epub 2006 Sep 20.

PMID:
17298921
19.
20.

Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.

Muehlen M, Schreiber J, Ehrhardt S, Otchwemah R, Jelinek T, Bienzle U, Mockenhaupt FP.

Trop Med Int Health. 2004 Mar;9(3):361-3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk